mHealth platforms for chronic care get the green light from the FDA

Federal regulators have signaled their support for a pair of mHealth platforms that use digital therapeutic tools to improve chronic care management.

The U.S. Food and Drug Administration has granted clearance to EndeavorRx, a connected health treatment that uses video game technology to approve attention function in children with attention-deficit/hyperactivity disorder (ADHD). The platform, to be made available by prescription, was developed by Boston-based Akili Interactive.

View this post on